Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Beam stock launched Monday after the company reached a deal with the Food and Drug Administration for its gene-editing drug, ...

A baby who is the first patient in the world to be successfully treated with customized CRISPR gene editing therapy is finally returning home from the hospital. Nine-month-old KJ Muldoon of Clifton ...

LOS ANGELES (KABC) -- It's been more than a month since the FDA approved two milestone gene-editing treatments for sickle cell disease, but lining up patients for these therapies will be a challenge ...

Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...